GovBidAlerts
← All opportunities

Bupropion HCL ER

All open bids & awards from Department of Defense →

Key dates

Posted
Sep 14, 2026
Response deadline
—
Archive date
Oct 6, 2028
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Award Notice
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
097.97AS.DLA TRP SUPT MED.SPE2D2
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Hauppauge
State
New York
Zip
11788
Country
UNITED STATES

Contacts

Description

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

Attachments (11)

Award

Number
SPE2D2-23-D-0002
Amount
$23,278,523.95
Date
Oct 6, 2022
Awardee
RADHA PHARMACEUTICALS INC Hauppauge NY 11788 USA
UEI
—
Awardee address
Hauppauge, New York, 11788, UNITED STATES

Other notices in this solicitation

Similar open contracts

Metadata

Notice ID
885609e0a0a44507927f0fb893d641d5
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
097.97AS.DLA TRP SUPT MED.SPE2D2
Ingested
Sep 15, 2026
Updated
Sep 29, 2026